참고문헌
- Leaute-Labreze C, Prey S, Ezzedine K. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011;25:1254-60. https://doi.org/10.1111/j.1468-3083.2011.04105.x
- Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. https://doi.org/10.1056/NEJMc0708819
- Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341:173-81. https://doi.org/10.1056/NEJM199907153410307
- Tan ST, Velickovic M, Ruger BM, Davis PF. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000;106:529-38. https://doi.org/10.1097/00006534-200009010-00001
- Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22. https://doi.org/10.1097/00006534-198203000-00002
- Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006;118:882-7. https://doi.org/10.1542/peds.2006-0413
- Beck DO, Gosain AK. The presentation and management of hemangiomas. Plast Reconstr Surg 2009;123:181e-91e. https://doi.org/10.1097/PRS.0b013e3181a65c59
- Greinwald JH Jr, Burke DK, Bonthius DJ, Bauman NM, Smith RJ. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999;125: 21-7. https://doi.org/10.1001/archotol.125.1.21
- Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Mac Donald D, Folkman J, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132 (3 Pt 1):527-30. https://doi.org/10.1016/S0022-3476(98)70034-4
- Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57:168-71. https://doi.org/10.1016/j.bjps.2003.11.003
- Wharton S, Soucid A, Nishikawa H, Sridhar AV. Endangering cutaneous infantile hemangioma treated with vincristine: a case report. Eur J Plast Surg 2009;32:157-61. https://doi.org/10.1007/s00238-008-0295-2
- Sondhi V, Patnaik SK. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol. J Pediatr Hematol Oncol 2013;35:493-9. https://doi.org/10.1097/MPH.0b013e3182a11658
- Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-31. https://doi.org/10.1542/peds.2008-3458
- Love JN, Sikka N. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med 2004;26:309-14. https://doi.org/10.1016/j.jemermed.2003.11.015
- Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-72. https://doi.org/10.1016/j.ijporl.2009.04.025
- Fuchsmann C, Quintal MC, Giguere C, Ayari-Khalfallah S, Guibaud L, Powell J, et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011;137: 471-8. https://doi.org/10.1001/archoto.2011.55
- Chik KK, Luk CK, Chan HB, Tan HY. Use of propranolol in infantile haemangioma among Chinese children. Hong Kong Med J 2010; 16:341-6.
- Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846; author reply 2846-7. https://doi.org/10.1056/NEJMc086443
- Haggstrom AN, Beaumont JL, Lai JS, Adams DM, Drolet BA, Frieden IJ, et al. Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol 2012;148: 197-202. https://doi.org/10.1001/archdermatol.2011.926
- Chakkittakandiyil A, Phillips R, Frieden IJ, Siegfried E, Lara-Corrales I, Lam J, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012;29:28-31. https://doi.org/10.1111/j.1525-1470.2011.01664.x
- Xiao Q, Li Q, Zhang B, Yu W. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence. Pediatr Surg Int 2013;29:575-81. https://doi.org/10.1007/s00383-013-3283-y
- Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kuebler I, Michels R, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011;170:493-501. https://doi.org/10.1007/s00431-010-1324-2
피인용 문헌
- Update March 2016 vol.14, pp.1, 2015, https://doi.org/10.1089/lrb.2016.29000.fb
- Update on recent research into infantile hemangioma vol.59, pp.9, 2015, https://doi.org/10.5124/jkma.2016.59.9.698
- Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response vol.9, pp.None, 2015, https://doi.org/10.3389/fimmu.2018.00164
- Treatment of Facial Infantile Hemangioma: Comparative Study Between Propranolol and Ethanolamine Oleate vol.29, pp.6, 2015, https://doi.org/10.1097/scs.0000000000004573
- Propranolol inhibits the activity of PI3K, AKT, and HIF-1α in infantile hemangiomas vol.34, pp.11, 2015, https://doi.org/10.1007/s00383-018-4347-9
- Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol vol.98, pp.6, 2015, https://doi.org/10.1097/md.0000000000014346
- Infantile Hemangioma: An Updated Review vol.16, pp.None, 2015, https://doi.org/10.2174/1573396316666200508100038
- The effectiveness and safety of topical β‐receptor blocker in treating superficial infantile haemangiomas: A meta‐analysis including 20 studies vol.86, pp.2, 2015, https://doi.org/10.1111/bcp.14196
- Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes vol.88, pp.5, 2020, https://doi.org/10.1038/s41390-020-0862-1
- Update on infantile hemangioma vol.64, pp.11, 2021, https://doi.org/10.3345/cep.2020.02061